12-Month Lobbying Summary - In-house Corporation

Return to 12-Month Lobbying Activity Search Results

AbbVie Corporation / RAMI FAYED, Vice President and General Manager, Canada

Registration Summary

Active - Last Updated: 2024-02-01

Who is lobbying?

AbbVie Corporation (Address & business activities)

RAMI FAYED, Vice President and General Manager, Canada

Responsible officer in previous versions
- Tracey Ramsay, Vice President and General Manager, Canada

Received government funding or funding expected in current financial year

Business Relationships

AbbVie Corporation is a subsidiary of the following parent companies

AbbVie (Address information)

Beneficiaries of the Lobbying Activity

AbbVie Corporation does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

What is being lobbied?

Subject Matters

Aboriginal Affairs
Budget
Economic Development
Federal-Provincial Relations
Health
Industry
Intellectual Property
International Trade
Research and Development
Science and Technology
Taxation and Finance

Subject Matter Details

Legislative Proposal, Bill or Resolution, Policies or Program, Regulation

Communications regarding national pharmacare legislation, regulations, policies or programs.

Policies or Program

Communications regarding access to and approval of medicines addressing the growing public health threat of antimicrobial resistance.
Communications regarding the design and implementation of the federal Drugs for Rare Diseases strategy.
Communications regarding the value assessment of new medicines by the Canadian Drug Agency (CDA) and the design of proposed new work streams, insofar as the federal government is a funder and holds a seat on the Board of Directors.
Communications with Health Canada regarding guidelines for pediatric action plans.
Communications with Health Canada regarding the application of its nitrosamine guidelines.
Engagement with Health Canada’s Regulatory Operations & Enforcement branch regarding supply chain resilience & integrity; mitigating and alleviating drug shortages.
Federal Government Non Insured Health Benefits program with respect to reimbursement of a prescription medicine and changes in type of reimbursement
Innovation, Science and Economic Development (ISED)'s Biomanufacturing and Life Sciences Strategy, pertaining to growth and development of the life sciences industry in Canada.
Patented Medicine Prices Review Board (PMPRB) Guidelines with regard to prices charged by Rights Holders for patented medicines sold in Canada.
Public Health Agency of Canada, regarding the federal response to the hepatitis C virus.
The pan Canadian Pharmaceutical Alliance (pCPA) with respect to public formulary listing of new medicines, insofar as the federal government is a participating jurisdiction and holds a seat on the Board of Directors.

Policies or Program, Regulation

Communications regarding Health Canada's Regulatory Innovation Agenda regarding proposed regulatory amendments and guidelines to enable agile licensing of drugs and medical devices.
Communications regarding intellectual property protection of prescription drugs, including the Patent Act, the Patented Medicines Regulations, the Patented Medicine Notice of Compliance (PMNOC) Regulations, the Patent Term Adjustment regime and Health Canada’s Data Protection regime.
Communications with Health Canada regarding modernization of clinical trials regulations, including diversity and inclusivity of clinical trials.
Communications with Health Canada regarding the evolution of the regulatory framework to address advanced therapeutic products.
Communications with Heath Canada regarding modernization of the medical devices regulatory framework.

Subject matter details in previous versions
Legislative Proposal, Bill or Resolution, Policies or Program
- Pharmaceutical intellectual property proposals that are part of the Comprehensive Economic and Trade Agreement with the European Union.
Legislative Proposal, Bill or Resolution, Policies or Program, Regulation
- Acts that propose to amend the Food and Drug Act and amendments to the Food and Drug Regulations related to the regulation of pharmaceuticals, biologic therapies, medical devices and foods.
- Communications regarding a national pharmacare program and Canada Drug Agency.
- Innovation, Science and Economic Development Canada (PMNOC) Regulations, as this relates to regulating intellectual property of prescription drugs; as well as discussions pertaining to growth and development of the life sciences industry in Canada, including as part of an Innovation Agenda.
Legislative Proposal, Bill or Resolution, Regulation
- Similar Entry Biologics (SEBs): requiring a Health Canada regulatory framework that support the approval of SEBs
Policies or Program
- Canada's Drug and Health Technology Agency (CADTH) and the pan Canadian Pharmaceutical Alliance (pCPA), with respect to value assessment and public formulary listing of new medicines.
- Common Drug Review (CDR), with respect to health economics assessment and recommendations made on new medicines.
Policies or Program, Regulation
- Implementation of Patented Medicine Notice of Compliance (PMNOC) Regulations and Patent Term Adjustment regime, as this relates to intellectual property protection of prescription drugs.
Regulation
- Patented Medicine Prices Review Board (PMPRB) Regulations. with regard to prices charged by patentees for patented medicines sold in Canada.

Who is being lobbied?

Government Institutions

Atlantic Canada Opportunities Agency (ACOA)
Canadian Institutes of Health Research (CIHR)
Correctional Service of Canada (CSC)
Employment and Social Development Canada (ESDC)
Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Immigration and Refugee Board (IRB)
Indigenous Services Canada (ISC)
Innovation, Science and Economic Development Canada (ISED)
Intergovernmental Affairs Secretariat (IGA)
Invest in Canada Hub
National Defence (DND)
National Research Council (NRC)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Public Health Agency of Canada (PHAC)
Public Services and Procurement Canada (PSPC)
Royal Canadian Mounted Police (RCMP)
Senate of Canada
Treasury Board Of Canada Secretariat (TBS)
Veterans Affairs Canada (VAC)

Communication techniques

Communication techniques that have been used or are expected to be used in the course of the undertaking:

Written communication
Oral communication
Arrange one or more meetings

Who are the lobbyists?

Senior Officers whose lobbying activities represent less than 20% of their Duties

Stephane Barakat, Head, Market Access & HEOR, Oncology | No public offices held
Christine Eleia, Head, Market Access & HEOR, Immunology | No public offices held
Caroline Jacques, Senior Counsel, Canada | No public offices held
Thula Kanagenthiran, Head, Market Access & HEOR, Specialty | No public offices held
Corry McElrea, Head, Field Market Access & Government Affairs | No public offices held
Amber McLeod, Lead, Regulatory Affairs | No public offices held
Judith Mergl, Director, Regulatory Affairs | No public offices held
Steve Popp, Head, Strategic Pricing & Contracting | No public offices held
Arima Ventin, Executive Director, Market Access and Government Affairs | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Sara Chahab, Field Lead, Market Access & Government Affairs - Immunology | No public offices held
Adam Cook, Manager, Market Access and Government Affairs, Ontario & Federal Programs | No public offices held
Catherine Desjardins, Field Lead, Market Access & Government Affairs - Oncology | No public offices held
Lauren Fischer, Lead, Government Affairs & Policy | No public offices held
Harold Just, Manager, Market Access and Government Affairs - Oncology | No public offices held
David Link, Field Lead, Market Access & Government Affairs - Specialty | No public offices held
Claude Longpre, Manager, Government Affairs, Quebec | No public offices held
Eric Pegolo, Manager, Market Access and Government Affairs, Ontario | No public offices held

Lobbyists in previous versions
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Kevin Bernard, Manager, Government Affairs & Policy | Designated public offices held
- Adam Cook, Manager, Market Access and Government Affairs, Ontario & Federal Programs | No public offices held
- David Link, Regional Manager Market Access & Government Affairs | No public offices held
- Christina Pelizon, Medical Director | No public offices held
- Tracey Ramsay, Vice President and General Manager, AbbVie Canada | No public offices held
- Catherine Robert, Senior Manager, Market Access and Health Economics | No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
- David Link, Regional Manager Market Access & Government Affairs | No public offices held
- Steve Popp, Lead, Pricing & Contracting | No public offices held
- Dale Yakutchik, Manager, Market Access and Government Affairs, Atlantic | No public offices held
- Dale Yakutchik, Provincial Affairs Manager, Atlantic | No public offices held

Registration number: 957373-15270
View all registrations versions

Monthly Communication Reports

What oral and arranged communications have taken place?

What oral and arranged communications have taken place?
Date	DPOH, Position Title \| Government Institution	Subject Matters
2024-04-15	Francis Bilodeau, Associate Deputy Minister \| Office of the Associate Deputy Minister, Innovation, Science and Economic Development Canada (ISED) Andrea Johnston, Assistant Deputy Minister Innovation, Science and Economic Development Canada (ISED) Etienne-Rene Massie, Assistant Deputy Minister Innovation, Science and Economic Development Canada (ISED)	Health, Industry
2024-04-15	Mark Schaan, Senior Assistant Deputy Minister Innovation, Science and Economic Development Canada (ISED)	Industry
2024-04-03	Ritu Banerjee, Assistant Deputy Minister \| Director General's Office, Innovation, Science and Economic Development Canada (ISED) Christopher Johnstone, Assistant Deputy Minister Health Canada (HC)	Industry, Research and Development
2024-02-12	William Messier, Quebec Advisor to the Minister of Innovation, Science and Industry Innovation, Science and Economic Development Canada (ISED)	Health, Industry
2023-12-19	Helena Jaczek, Member of Parliament House of Commons	Health, Industry
2023-11-09	Ritu Banerjee, Assistant Deputy Minister \| Director General's Office, Innovation, Science and Economic Development Canada (ISED) Laurel Broten, Chief Executive Officer Invest in Canada Hub Bobby Kelly, Chief of Staff Invest in Canada Hub Kelley Parato, Director \| Human Health Therapeutics Research Centre, National Research Council (NRC)	Health, Industry, Science and Technology
2023-10-26	Paul Chiang, Member of Parliament House of Commons	Health, Industry
2023-10-20	Eshan Naik, Director of Policy \| Office of the Minister of Health, House of Commons	Health
2023-08-31	Stan Kutcher, Senator Senate of Canada	Health
2023-07-27	Yash Nanda, Policy Advisor Finance Canada (FIN)	Health, Industry

View all monthly communication reports

Return to 12-Month Lobbying Activity Search Results

AbbVie Corporation - Address & business activities

Address:

8401 Transcanada Highway
St-Laurent, QC H4S 1Z1
Canada

Telephone number: 888-703-3006

Contact information in previous versions
- 8401 Transcanada Highway
  St-Laurent, QC H4S 1Z1
  Canada
  
  Telephone number: 514-832-7123
- 8401 Transcanada Highway
  St-Laurent, QC H4S 1Z1
  Canada
  
  Telephone number: 514-906-9700
- 8401 Transcanada Highway
  St-Laurent, QC H4S 1Z1
  Canada
  
  Telephone number: 514-832-7126
  
  Fax number: 514-832-7858
- 8401 Transcanada Highway
  St-Laurent, QC H4S 1Z1
  Canada
  
  Telephone number: 514-832-7126
  
  Fax number: 514-832-7858
- 8401 Transcanada Highway
  St-Laurent, QC H4S 1Z1
  Canada
  
  Telephone number: 514-832-7126
  
  Fax number: 514832 7858
- 8401 Transcanada Highway
  St-Laurent, QC H4S 1Z1
  Canada
  
  Telephone number: 514-832-7429
  
  Fax number: 514832 7865

Description of activities:
AbbVie is a global, research-based biopharmaceutical company formed in 2013. We use our expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.

Descriptions of the corporation's activity in previous versions:
- AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. With its 125-year history, the company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.
- Abbott is a broad-based health care company that discovers, develops, manufacturers and markets products that span the continuum of care - from prevention and diagnosis to treatment and cure. Abbott's principal businesses include medical products, including devices, diagnostic tests and instruments, nutritionals for children and adults, and pharmaceuticals.
- Abbott is a broad-based health care company that discovers, develops, manufactures and markets products that span the continuum of care - from prevention and diagnosis to treatment and cure. Abbott's principal businesses include medical products, including devices, diagnostic tests and instruments, nutritionals for children and adults, and pharmaceuticals.

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Senior Policy Analyst Minister of Labour, Minister's Office	January 2015 to October 2015	October 19, 2015

Date Modified:: 2024-04-04

Search and menus

Language selection

12-Month Lobbying Summary - In-house Corporation

AbbVie Corporation / RAMI FAYED, Vice President and General Manager, Canada

Who is lobbying?

AbbVie Corporation (Address & business activities)

Received government funding or funding expected in current financial year

Business Relationships

AbbVie Corporation is a subsidiary of the following parent companies

Beneficiaries of the Lobbying Activity

What is being lobbied?

Subject Matters

Subject Matter Details

Legislative Proposal, Bill or Resolution, Policies or Program, Regulation

Policies or Program

Policies or Program, Regulation

Legislative Proposal, Bill or Resolution, Policies or Program

Legislative Proposal, Bill or Resolution, Policies or Program, Regulation

Legislative Proposal, Bill or Resolution, Regulation

Policies or Program

Policies or Program, Regulation

Regulation

Who is being lobbied?

Government Institutions

Communication techniques

Who are the lobbyists?

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

What oral and arranged communications have taken place?